A Phase IIa randomized double-blind placebo controlled study to evaluate the safety and feasibility of oral triheptanoin as an add-on treatment to adolescent and adult patients with medically refractory epilepsy

Trial Profile

A Phase IIa randomized double-blind placebo controlled study to evaluate the safety and feasibility of oral triheptanoin as an add-on treatment to adolescent and adult patients with medically refractory epilepsy

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Acronyms TRIP-E
  • Most Recent Events

    • 08 Jun 2016 Status changed from recruiting to completed.
    • 15 Aug 2012 Actual initiation date (Apr 2012) added as reported by Australian New Zealand Clinical Trials Registry.
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top